The competitive program selected three early- and venture-stage companies from around the world that are using quantum computing to advance research and patient care. The awards support a wide array of research goals, including investigating how genetic variants cause rare diseases; enhancing AI to predict drug toxicity; and building quantum-enhanced simulations to predict real-time cardiovascular risk.

Read more here.